D.M. Kowalski

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

D.M. Kowalski is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, lung cancer pharmacotherapy, and non-small cell lung cancer therapy.

Publications per year

2022–2025

Publications

Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial

E. Felip, C.I. Rojas, M. Schenker et al. · Annals of Oncology · 2025 · 28 citations · Full text

Medicine, Oncology, Pharmacology +13

OA15.06 Pooled Analysis of Outcomes with Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer

Delvys Rodríguez‐Abreu, Y.-L. Wu, M. Boyer et al. · Journal of Thoracic Oncology · 2022 · 13 citations

Medicine, Oncology, Pharmacotherapy +9

1–2 of 2